In Vitro Diagnostics (IVD) Market Estimated to reach at $93,614 million by 2025 – Abbott Laboratories, Becton, Dickinson and Company, bioMrieux, Bio-Rad Laboratories, Danaher Corporation

The global in vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.

In vitro diagnostic (IVD) is a technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point of care. Some of the significant technologies incorporated in IVD include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product type design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.

FREE| Download Sample Copy at https://www.reportsweb.com/inquiry&RW00012658727/sample

Rise in need for IVD testing arises due to increase in incidences of chronic and infectious diseases and growth in geriatric population prone to immunological disorders. Moreover, advancements in personalized medicines and widespread knowledge of rare diseases are expected to boost the growth of the global IVD market. In addition, increase in incidences of colorectal cancer, neurological disorders, and gynecological diseases are anticipated to boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavorable reimbursement policies are expected to restrain the growth of the global market.

The report segments the market across different categories such as product type, technique, application, end users, and region. Based on product type, the market is segmented into reagents, instruments, and services & software.
Based on techniques, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. The immunodiagnostics is further segmented into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. The ELISA segment is further classified into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Molecular diagnostics segment is further divided into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarrays, and others. Similarly, clinical chemistry segment is categorized into basic metabolic panel, liver panel, lipid profile, thyroid function panel, renal profile, electrolyte panel, and specialty chemicals.

By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is divided into hospitals, academic & medical schools, point of care testing, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key players profiled in the report include Abbott Laboratories; Becton, Dickinson and Company; bioM?rieux SA, Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Johnson & Johnson; QIAGEN N.V.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.

 Inquire for Report at https://www.reportsweb.com/inquiry&RW00012658727/buying

 Key Benefits for IVD Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

List Of Key Players Profiled in the Report

Abbott Laboratories
Becton, Dickinson and Company
bioM?rieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
QIAGEN N.V.
Sysmex Corporation
Thermo Fisher Scientific, Inc.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)

Illumina, Inc.
Luminex Corporation.
Siemens Healthcare GmbH.

 TABLE OF CONTENTS:

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE

CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE

CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION

CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER

CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES

Purchase this Premium Research Report at https://www.reportsweb.com/buy&RW00012658727/buy/5370

 About ReportsWeb:

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:

Call: +1-646-491-9876
Email: [email protected]

Posted by on Tuesday June 18 2019, 5:15 AM EDT. All trademarks acknowledged. Filed under Diagnostics, Featured Press Release, Healthcare, Life Sciences. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in